174 related articles for article (PubMed ID: 27510666)
1. Expression of CD71 by flow cytometry in acute leukemias: More often seen in acute myeloid leukemia.
Pande A; Dorwal P; Jain D; Tyagi N; Mehra S; Sachdev R; Raina V
Indian J Pathol Microbiol; 2016; 59(3):310-3. PubMed ID: 27510666
[TBL] [Abstract][Full Text] [Related]
2. Significance of CD71 expression by flow cytometry in diagnosis of acute leukemia.
Liu Q; Wang M; Hu Y; Xing H; Chen X; Zhang Y; Zhu P
Leuk Lymphoma; 2014 Apr; 55(4):892-8. PubMed ID: 23962073
[TBL] [Abstract][Full Text] [Related]
3. Role of CD71 in acute leukemia- An immunophenotypic marker for erythroid lineage or proliferation?
Acharya S; Kala PS
Indian J Pathol Microbiol; 2019; 62(3):418-422. PubMed ID: 31361230
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Transferrin Receptor-1 (CD71) Expression in Acute Lymphoblastic Leukemia.
Hagag AA; Badraia IM; Abdelmageed MM; Hablas NM; Hazzaa SME; Nosair NA
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):610-617. PubMed ID: 29875008
[TBL] [Abstract][Full Text] [Related]
5. T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiation.
Dorfman DM; Morgan EA; Pelton A; Unitt C
Hum Pathol; 2017 Jul; 65():166-174. PubMed ID: 28551327
[TBL] [Abstract][Full Text] [Related]
6. Triphenotypic acute leukemia with TRAP-positive blasts: A pathological rarity.
Sharma P; Asthana B; Tyagi S
Leuk Res; 2009 Jul; 33(7):e83-4. PubMed ID: 19237193
[No Abstract] [Full Text] [Related]
7. Cytometric evaluation of transferrin receptor 1 (CD71) in childhood acute lymphoblastic leukemia.
Płoszyńska A; Ruckemann-Dziurdzińska K; Jóźwik A; Mikosik A; Lisowska K; Balcerska A; Witkowski JM
Folia Histochem Cytobiol; 2012 Jul; 50(2):304-11. PubMed ID: 22763969
[TBL] [Abstract][Full Text] [Related]
8. CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens.
Marsee DK; Pinkus GS; Yu H
Am J Clin Pathol; 2010 Sep; 134(3):429-35. PubMed ID: 20716799
[TBL] [Abstract][Full Text] [Related]
9. NRP-1/CD304 expression in acute leukemia: a potential marker for minimal residual disease detection in precursor B-cell acute lymphoblastic leukemia.
Meyerson HJ; Blidaru G; Edinger A; Osei E; Schweitzer K; Fu P; Ho L
Am J Clin Pathol; 2012 Jan; 137(1):39-50. PubMed ID: 22180477
[TBL] [Abstract][Full Text] [Related]
10. Somatic mutation of IL7R exon 6 in acute leukemias and solid cancers.
Kim MS; Chung NG; Kim MS; Yoo NJ; Lee SH
Hum Pathol; 2013 Apr; 44(4):551-5. PubMed ID: 23069254
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of high expression level of CD71 in acute myeloid leukemia.
Wu B; Shi N; Sun L; Liu L
Neoplasma; 2016; 63(5):809-15. PubMed ID: 27468886
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
13. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
Glasová M; Koníková E; Stasáková J; Babusíková O
Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
[TBL] [Abstract][Full Text] [Related]
14. CD71 is selectively and ubiquitously expressed at high levels in erythroid precursors of all maturation stages: a comparative immunochemical study with glycophorin A and hemoglobin A.
Dong HY; Wilkes S; Yang H
Am J Surg Pathol; 2011 May; 35(5):723-32. PubMed ID: 21415701
[TBL] [Abstract][Full Text] [Related]
15. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
Haouas H; Haouas S; Uzan G; Hafsia A
Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
[TBL] [Abstract][Full Text] [Related]
16. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination.
Thalhammer-Scherrer R; Mitterbauer G; Simonitsch I; Jaeger U; Lechner K; Schneider B; Fonatsch C; Schwarzinger I
Am J Clin Pathol; 2002 Mar; 117(3):380-9. PubMed ID: 11888077
[TBL] [Abstract][Full Text] [Related]
17. CD72 is a pan-tumor antigen associated to pediatric acute leukemia.
Buldini B; Faggin G; Porcù E; Scarparo P; Polato K; Tregnago C; Varotto E; Rizzardi P; Rizzari C; Locatelli F; Biffi A; Pigazzi M
Cytometry A; 2023 Dec; 103(12):1004-1009. PubMed ID: 37876342
[TBL] [Abstract][Full Text] [Related]
18. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
[TBL] [Abstract][Full Text] [Related]
19. Importance of Acute Lymphoblastic Leukemia-type Therapy for Bilineal Acute Leukemia.
Nakagawa S; Okamoto Y; Kodama Y; Nishikawa T; Tanabe T; Kawano Y
J Pediatr Hematol Oncol; 2019 Aug; 41(6):504-506. PubMed ID: 30198961
[TBL] [Abstract][Full Text] [Related]
20. CD317 is over-expressed in B-cell chronic lymphocytic leukemia, but not B-cell acute lymphoblastic leukemia.
Gong S; Osei ES; Kaplan D; Chen YH; Meyerson H
Int J Clin Exp Pathol; 2015; 8(2):1613-21. PubMed ID: 25973046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]